Insmed Inc. buy Wells Fargo & Company
Start price
01.04.24
/
50%
€24.80
Target price
01.04.25
€51.22
Performance (%)
-6.45%
Price
03.05.24
€23.60
Summary
This prediction is currently active. With a performance of -6.45%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 01.04.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 2.609% | 2.609% |
| iShares Core DAX® | -0.922% | -1.078% |
| iShares Nasdaq 100 | 0.371% | -0.556% |
| iShares Nikkei 225® | 2.224% | -2.825% |
| iShares S&P 500 | -0.026% | -0.788% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $55.00 price target on the stock.
Ratings data for INSM provided by MarketBeat